Editorial Commentary
Online First
The articles on this page have been copyedited and reviewed and approved by the authors. They have not yet been scheduled for a specific issue. For published content, please visit Archive.
Editorial Commentary
Durvalumab and olaparib with chemotherapy improve progression-free survival in first-line metastatic endometrial cancer: a new promising combination strategy?
Editorial Commentary
A review: patient questions about use of vaginal ring pessaries for prolapse
Editorial Commentary
Prognostic analysis of single-agent olaparib or combination cediranib and olaparib for platinum sensitive recurrent ovarian cancer: overall survival outcomes from NRG-GY004
Editorial Commentary
Unveiling disparities in urogynecologic surgery research: insights into impact and equity
Editorial Commentary
Improving survival in recurrent ovarian cancer, miles to go before we sleep
Editorial Commentary
Atezolizumab with chemotherapy for advanced or recurrent endometrial cancer: does targeting PD-1 or PD-L1 matter in this clinical situation?
Editorial Commentary
On the complementary role of perineal ultrasound in evaluating female pelvic organ prolapse
Editorial Commentary